FARALLON CAPITAL MANAGEMENT LLC

Q1 2025 13F-HR Detailed Holdings

Location
San Francisco, CA
Holdings as of
3/31/2025
Date filed
5/15/2025
Form type
13F-HR
Num holdings
135
Total value ($000)
$17,935,797
Net value change ($000)
-1,782,501 (-9.0%)
New positions
16
Sold out positions
13
Turnover %
9.3%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Intra-Cellular Therapies, Inc. 403,016 NEW
MSFT 169,709 24.7%
ARMK 134,954 31.7%
CRM 123,309 30.5%
LNTH 112,277 23.6%
BBIO 83,010 72.1%
SGI 79,415 NEW
VRNA 68,886 NEW
PTGX 66,437 29.0%
SCHW 65,498 27.9%
Top Reduces (Value $000, Stocks/ETFs)
ABNB -319,221 -100.0%
AON -279,907 -42.5%
SRPT -198,938 -57.1%
BMY -180,313 -100.0%
GOOGL -135,933 -34.3%
TMO -126,135 -19.7%
IBIT -113,887 -29.6%
RVMD -100,911 -17.4%
EDU -89,011 -58.8%
YMM -85,499 -47.6%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,306,427 (12.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None